Elevance Health
ELV
Market cap $93.6B

403.60 USD

+6.12

1.54%

At close Nov 21, 4:00 PM EST

After hours

403.60

+0.00

0.00%

1 day

1.54%

5 days

-0.35%

1 month

-4.42%

3 months

-25.58%

6 months

-26.03%

Year to date

-15.71%

1 year

-14.24%

5 years

37.41%

10 years

212.48%

About: Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 47 million medical members as of December 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.

Employees: 104,900

Financials Hospital & Medical Service Plans

0

Funds holding %

of 6,747 funds

0

Analysts bullish %

of 14 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

12% more repeat investments, than reductions

Existing positions increased: 652 | Existing positions reduced: 581

4% less call options, than puts

Call options by funds: $620M | Put options by funds: $645M

2% less funds holding

Funds holding: 1,672 [Q2] → 1,636 (-36) [Q3]

3.39% less ownership

Funds ownership: 90.69% [Q2] → 87.3% (-3.39%) [Q3]

4% less funds holding in top 10

Funds holding in top 10: 52 [Q2] → 50 (-2) [Q3]

8% less capital invested

Capital invested by funds: $114B [Q2] → $104B (-$9.67B) [Q3]

21% less first-time investments, than exits

New positions opened: 133 | Existing positions closed: 169

See Fund Rankings

Research analyst outlook

14 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$478

18%

upside

Avg. target

$544

35%

upside

High target

$622

54%

upside

14 analyst ratings

14 positive

100%

0 neutral

0%

0 negative

0%

Mizuho Ann Hynes 0 / 0 met price target	25%upside $505	Outperform Maintained	5 Nov 2024
Wells Fargo Stephen Baxter 0 / 0 met price target	23%upside $495	Overweight Maintained	4 Nov 2024
Morgan Stanley Erin Wright 0 / 0 met price target	37%upside $551	Overweight Maintained	23 Oct 2024
Barclays Andrew Mok 0 / 0 met price target	24%upside $501	Overweight Maintained	22 Oct 2024
TD Cowen Ryan Langston 0 / 0 met price target	20%upside $484	Buy Maintained	21 Oct 2024

See Analyst Rankings

Financial journalist opinion

Based on 10 articles about ELV published over the past 30 days

Elevance Health, Inc. Shareholders are Encouraged to Reach Out to Johnson Fistel for More Information about Potentially Recovering Their Losses

SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Elevance Health, Inc. (NYSE: ELV) or any of its executive officers violated securities laws by misrepresenting or failing to timely disclose material information to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws.

Elevance Health, Inc. Shareholders are Encouraged to Reach Out to Johnson Fistel for More Information about Potentially Recovering Their Losses

Elevance Health, Inc. (ELV) UBS Global Healthcare Conference (Transcript)

Elevance Health, Inc. (NYSE:ELV ) UBS Global Healthcare Conference November 12, 2024 10:15 AM ET Company Participants Mark Kaye - Executive VP & CFO Conference Call Participants A.J. Rice - UBS A.J.

Elevance Health, Inc. (ELV) UBS Global Healthcare Conference (Transcript)

Zacks Investment Research

Elevance Health Declines 20% in 3 Months: Time to Sell the Stock?

ELV encounters headwinds such as higher benefit costs, an increased debt level and member attrition in the Medicaid business, which raise concerns among investors.

Elevance Health Declines 20% in 3 Months: Time to Sell the Stock?

Elevance Health, Inc. Shareholders are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Elevance Health, Inc. (NYSE: ELV) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws.

Elevance Health, Inc. Shareholders are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Elevance Health Announces Appearance at UBS Global Healthcare Conference

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the UBS Global Healthcare Conference in Rancho Palos Verdes, California on November 12, at 7:15 a.m. Pacific Standard Time (PST) / 10:15 a.m. Eastern Standard Time (EST). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may also access the link here. For those unab.

Elevance Health Announces Appearance at UBS Global Healthcare Conference

Elevance Health Appoints Nathan Rich Vice President, Investor Relations

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today the appointment of Nathan Rich as Vice President, Investor Relations, effective November 11, 2024. In this role, Mr. Rich will lead Elevance Health's investor relations efforts, providing strategic leadership to support the company's growth initiatives and strengthen relationships within the investment community. He will also serve as a member of the company's executive leadership team and will report directly to Mark Ka.

Elevance Health Appoints Nathan Rich Vice President, Investor Relations

My Top 15 High-Growth Dividend Stocks For November 2024

The SPDR S&P 500 ETF Trust posted a loss of 0.89% in October, putting a pause on its strong run in 2024. The Top 15 dividend growth stocks for November 2024 offer an average dividend yield of 1.24% and appear to be about 23% undervalued based on dividend yield theory. Since its inception in September 2020, the watch list has achieved an 11.33% compound annual growth rate.

My Top 15 High-Growth Dividend Stocks For November 2024

These are the S&P 500's biggest laggards for October, down by as much as 29%

Super Micro joined the list after a 33% drop on Wednesday.

These are the S&P 500's biggest laggards for October, down by as much as 29%

Elevance Health Foundation Names Professional Football Player Ryan Kelly as Next Elevance Health Champion

INDIANAPOLIS--(BUSINESS WIRE)-- #maternalhealth--The Elevance Health Foundation, the philanthropic arm of Elevance Health, today announces professional football player Ryan Kelly as its latest Elevance Health Champion. Designed to help increase awareness for critical health challenges and raise funds for local organizations that are making a healthy difference in their communities, the Elevance Health Champion program recognizes professional athletes and organizations who have dedicated their life to leading hea.

Elevance Health Foundation Names Professional Football Player Ryan Kelly as Next Elevance Health Champion

AM Best Assigns Issue Credit Ratings to Elevance Health, Inc. New Senior Unsecured Bonds

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has assigned a Long-Term Issue Credit Rating of “bbb+” (Good) to Elevance Health, Inc.'s (Elevance Health) (Indianapolis, IN) newly issued $350 million, 4.5% senior unsecured bonds, due 2026; $750 million, 4.750% senior unsecured bonds, due 2030; $750 million, 4.95% senior unsecured bonds, due 2031; $1.2 billion, 5.2% senior unsecured bonds, due 2035; $1.35 billion, 5.7% senior unsecured bonds, due 2055; and $800 million, 5.85% senior unsecured bonds, due.

AM Best Assigns Issue Credit Ratings to Elevance Health, Inc. New Senior Unsecured Bonds

See News Rankings

Charts implemented using Lightweight Charts™